Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8744 USD | +0.51% | +4.10% | +37.05% |
04-22 | HeartCore Enterprises Provides AI Capabilities to Heart-Tech Health | MT |
04-22 | Heartcore Enterprises, Inc. Expands Partnership with Heart-Tech Health | CI |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Capitalization 1 | 16.06 | 13.3 | 18.22 | - |
Enterprise Value (EV) 1 | 16.06 | 13.3 | 18.22 | 18.22 |
P/E ratio | -2.46 x | -3.04 x | 2.82 x | 2.57 x |
Yield | - | - | - | - |
Capitalization / Revenue | 1.82 x | 0.61 x | 0.75 x | 0.56 x |
EV / Revenue | 1.82 x | 0.61 x | 0.75 x | 0.56 x |
EV / EBITDA | -2.43 x | -3.87 x | 6.53 x | 2.21 x |
EV / FCF | - | - | - | - |
FCF Yield | - | - | - | - |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 17,650 | 20,843 | 20,843 | - |
Reference price 2 | 0.9100 | 0.6380 | 0.8744 | 0.8744 |
Announcement Date | 31/03/23 | 09/04/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net sales 1 | - | 8.818 | 21.85 | 24.16 | 32.39 |
EBITDA 1 | - | -6.613 | -3.436 | 2.79 | 8.233 |
EBIT 1 | - | -6.696 | -4.119 | 1.396 | 6.801 |
Operating Margin | - | -75.93% | -18.86% | 5.78% | 20.99% |
Earnings before Tax (EBT) 1 | - | -6.683 | -5.01 | 11.23 | 14.13 |
Net income 1 | -0.3382 | -6.677 | -4.19 | 9.2 | 11.5 |
Net margin | - | -75.72% | -19.18% | 38.07% | 35.49% |
EPS 2 | -0.0200 | -0.3700 | -0.2100 | 0.3100 | 0.3400 |
Free Cash Flow | - | - | - | - | - |
FCF margin | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 31/03/22 | 31/03/23 | 09/04/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales | - | 2 | - | - | 4.689 | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - |
EBIT | - | - | - | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - |
Net income | -1.971 | - | - | - | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - |
EPS 1 | -0.1100 | -0.0800 | 0.1000 | -0.0400 | -0.1100 | -0.1400 | 0.2600 | 0.0500 | 0.0600 | 0.0700 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 14/11/22 | 31/03/23 | 22/05/23 | 14/08/23 | 13/11/23 | 09/04/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex | - | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 31/03/22 | 31/03/23 | 09/04/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.05% | 18.22M | |
+9.17% | 3,051B | |
+6.91% | 83.97B | |
+3.74% | 76.9B | |
-13.73% | 54B | |
+25.57% | 48.01B | |
-24.95% | 46.47B | |
+19.54% | 42.04B | |
+64.81% | 38.34B | |
-14.63% | 24.97B |
- Stock Market
- Equities
- HTCR Stock
- Financials HeartCore Enterprises, Inc.